| 000 | 01482 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250514002441.0 | ||
| 264 | 0 | _c20010726 | |
| 008 | 200107s 0 0 eng d | ||
| 022 | _a0009-8981 | ||
| 024 | 7 |
_a10.1016/s0009-8981(01)00420-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLinder, M W | |
| 245 | 0 | 0 |
_aGenetic mechanisms for hypersensitivity and resistance to the anticoagulant Warfarin. _h[electronic resource] |
| 260 |
_bClinica chimica acta; international journal of clinical chemistry _cJun 2001 |
||
| 300 |
_a9-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 | _aAryl Hydrocarbon Hydroxylases |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDrug Hypersensitivity _xgenetics |
| 650 | 0 | 4 |
_aDrug Resistance _xgenetics |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMixed Function Oxygenases _xgenetics |
| 650 | 0 | 4 |
_aPolymorphism, Genetic _xgenetics |
| 650 | 0 | 4 | _aSteroid 16-alpha-Hydroxylase |
| 650 | 0 | 4 |
_aSteroid Hydroxylases _xgenetics |
| 650 | 0 | 4 |
_aThromboembolism _xdrug therapy |
| 650 | 0 | 4 | _aVitamin K Epoxide Reductases |
| 650 | 0 | 4 |
_aWarfarin _xadverse effects |
| 773 | 0 |
_tClinica chimica acta; international journal of clinical chemistry _gvol. 308 _gno. 1-2 _gp. 9-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0009-8981(01)00420-x _zAvailable from publisher's website |
| 999 |
_c11342826 _d11342826 |
||